RASD1 and plasma cell myeloma: Indeed, in a genome-wide methylation study of 115 primary myeloma samples using Illumina 27 K28, RASD1 methylation was inversely correlated with expression, hence further testifying the role of methylation-mediated silencing for RASD1 in myeloma patients.